Opaleye Management Inc. - Significant Ownership

Signature - Title
James Silverman - President
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Opaleye Management Inc..

Significant Ownership of Opaleye Management Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IBIO iBio, Inc. Common Stock, par value $0.001 per share 7.6% $4.16M 750K Opaleye Management, Inc. Dec 31, 2024
LRMR Larimar Therapeutics, Inc. Common Stock 6.17% $9.29M 3.95M Opaleye Management, Inc. Apr 9, 2025
TARA Protara Therapeutics, Inc. Common Stock, par value $0.001 per share 5.32% $7.43M 1.83M Opaleye Management, Inc. Dec 31, 2024
OCUL OCULAR THERAPEUTIX, INC Common Stock, par value $0.0001 per share 2.76% $36.6M 4.34M Opaleye Management Inc. Dec 31, 2024
CNTX Context Therapeutics Inc. Common Stock, par value $0.001 per share 0% $0 0 Opaleye Management Inc. Dec 31, 2024

Schedules 13D/G Reported by Opaleye Management Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.